{"database": "lobbying", "table": "lobbying_activities", "rows": [[2959532, "e5216ca2-442f-49b3-9a61-6d7399c86f6f", "Q1", "THE LIAISON GROUP, LLC", 401104378, "NATIONAL CANNABIS ROUNDTABLE", 2023, "first_quarter", "CSP", "Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and hemp-derived intoxicating products", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office", 0, 0, "2023-04-14T14:10:53-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2959532"], "units": {}, "query_ms": 58.81042298278771, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}